SPHK2 and acute respiratory distress syndrome: Previous studies have demonstrated that the inhibition of SPHK1 was shown to have potential therapeutic advantage against LPS-induced lung injury [7, 8], while the properties of SPHK2 in the pathogenesis of ALI are controversial.